Last reviewed · How we verify

NCT05169723

Respiratory Emissions in Healthy Participants

Completed NA Last updated 10 January 2025
What this trial tests

NA trial testing Exertional respiratory activities in Healthy in 40 participants. Completed in 9 January 2025.

Timeline
8 March 2022
Primary endpoint
1 March 2023
9 January 2025

Quick facts

Lead sponsorFisher and Paykel Healthcare
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposebasic science
Enrollment40
Start date8 March 2022
Primary completion1 March 2023
Estimated completion9 January 2025
Sites1 location across New Zealand

Drugs / interventions tested

Conditions studied

Sponsor

Fisher and Paykel Healthcare — full company profile →

Who can join

18 and older, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an randomised cross over trial in healthy participants measuring respiratory emissions during different respiratory activities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

Other Fisher and Paykel Healthcare trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05169723.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing